Russell Investments Group, Ltd. - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 62 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q1 2022$209,000
-20.2%
214,898
-18.2%
0.00%
Q2 2021$262,000
-90.4%
262,680
-90.5%
0.00%
-100.0%
Q4 2020$2,741,000
-12.7%
2,756,000
-14.8%
0.01%
-28.6%
Q3 2020$3,139,000
-7.4%
3,236,000
-7.5%
0.01%
-12.5%
Q2 2020$3,389,000
+6.5%
3,500,000
+1.8%
0.01%0.0%
Q1 2020$3,182,000
+0.4%
3,439,000
+2.9%
0.01%
+33.3%
Q4 2019$3,168,000
+355.2%
3,343,000
+334.7%
0.01%
+500.0%
Q3 2019$696,000
-49.2%
769,000
-48.6%
0.00%
-66.7%
Q2 2019$1,369,000
-22.6%
1,497,000
-22.0%
0.00%0.0%
Q1 2019$1,769,000
+4.1%
1,919,000
+2.0%
0.00%
-25.0%
Q4 2018$1,699,000
-6.0%
1,882,000
-2.6%
0.00%
+33.3%
Q3 2018$1,807,000
-13.7%
1,932,000
-14.5%
0.00%
-25.0%
Q2 2018$2,095,000
-19.5%
2,260,000
-23.9%
0.00%0.0%
Q1 2018$2,603,000
-17.3%
2,970,000
-16.7%
0.00%
-20.0%
Q4 2017$3,146,000
+47.3%
3,565,000
+82.5%
0.01%
+25.0%
Q4 2016$2,136,0001,953,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q4 2017
NameSharesValueWeighting ↓
ZAZOVE ASSOCIATES LLC 91,833,000$98,950,0005.16%
Ferox Capital Management LP 5,390,000$5,796,0002.37%
INCOME RESEARCH & MANAGEMENT 7,472,000$8,014,0002.17%
SPHERA FUNDS MANAGEMENT LTD. 14,535$8,641,0001.47%
Lombard Odier Asset Management (Europe) Ltd 21,660,000$23,433,0001.33%
SHENKMAN CAPITAL MANAGEMENT INC 11,864,000$12,783,0001.15%
MACKAY SHIELDS LLC 18,887,000$20,335,0000.86%
AEGON USA Investment Management, LLC 4,000,000$4,290,0000.84%
ADVENT CAPITAL MANAGEMENT /DE/ 32,751,000$35,196,0000.67%
PALISADE CAPITAL MANAGEMENT, LP 6,067,000$6,522,0000.24%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders